Web Focus
: 2008
Top of page
Focus on RNAi as a Therapeutic Strategy
Over 30 pharmaceutical and biotechnology companies have declared an interest in or have an active drug development program already underway in RNAi-based therapeutics to silence disease associated genes. This web focus collects together the latest research covering the development of RNAi based tools for drug target and gene function analysis as well as work describing the development of the technology for therapeutic applications.
: 2007
Top of page
Focus on Prostate Cancer and Gene Therapy
Prostate cancer affects one in six men and is the second leading cause of cancer death among men in the United States. In some cases existing treatments for early prostate cancer fail, leading to advanced stage cancer that is merely managed and not cured. Gene therapy shows promise as a treatment strategy that can target both localized and metastasized prostate cancer. Recent clinical trials of various gene therapy strategies have illustrated the safety of these therapies and their potential as an effective treatment option in conjunction with existing cancer therapies. This web focus, presented by Molecular Therapy, highlights some important research that has advanced the field of prostate cancer gene therapy.
